Month: September 2026

New specialty division of Kelly Science, Engineering, Technology & Telecom combines decades of industry expertise with Kelly’s scale to solve critical workforce needs across the digital infrastructure ecosystem

Facts at a Glance:

• Kelly Digital Infrastructure brings together Kelly Telecom, NextGen | GTA, and Motion Telco under one specialized brand that serves the entire ecosystem.
• Expertise of the new division spans telecom, data center, advanced AI, and automation services.
• The unified brand combines industry expertise with Kelly’s scale to deliver end-to-end workforce solutions, from staffing and direct hire to technical project services and managed programs.

TROY, Mich., Sept. 30, 2026 (GLOBE NEWSWIRE) — Kelly (Nasdaq: KELYA, KELYB), a global workforce strategy and solutions provider, today announced the launch of Kelly Digital Infrastructure, unifying the Kelly Telecom, NextGen | GTA, and Motion Telco businesses under a single specialty brand. Built on decades of deep domain expertise and industry partnerships, the new division brings together workforce capabilities that address client and talent needs across the digital infrastructure ecosystem, with a focus on telecom, data centers, AI, and automation.

“Kelly Digital Infrastructure is a natural evolution of the business we’ve built to help clients navigate increasingly complex workforce needs while connecting talent to opportunity across this rapidly growing industry,” said Mark Walker, President, Engineering & Digital Infrastructure at Kelly. “AI is reshaping digital infrastructure and the specialized workforce required to build and operate it. We are unifying our expertise and talent networks across telecom, data centers, AI, and automation to meet those needs.”

Demand for highly specialized digital infrastructure talent is surging. Human capital constraints are the largest bottleneck to data center development, fueling higher wages in both major markets and smaller communities, as well as talent poaching within the industry, according to the Kelly 2026 Data Center Salary Guide. Kelly’s analysis found salary premiums of up to 74% above the national benchmark for critical data center roles, underscoring the intensifying competition for specific talent as data center development expands across both established hubs and emerging markets.

“Organizations in the digital infrastructure ecosystem need access to specialized talent at every stage, from development and deployment through ongoing operations,” said Joel Leege, President of Science, Engineering, Technology & Telecom at Kelly. “As AI and cloud deployment accelerate data center growth at an unprecedented pace, developers and operators need a cohesive, end-to-end workforce strategy, and Kelly Digital Infrastructure brings the expertise and scale to deliver it.”

End-to-End Workforce Solutions for Digital Infrastructure

Industry organizations require comprehensive workforce strategies built to keep pace, from planning and development to deployment and daily operations. Kelly Digital Infrastructure helps clients address talent and project needs through all critical phases of the infrastructure lifecycle:

• Design & Planning: engineering, network design, site development, permitting, project management, infrastructure strategy, and data-driven planning
• Build & Deployment: construction and deployment support, fiber/OSP, wireless and RAN deployment, in-building and private networks, equipment installation, integration and commissioning
• Operations & Optimization: network and field operations, testing and optimization, PIM mitigation, infrastructure monitoring, AIOps, predictive fault detection, maintenance, and modernization
• Workforce Development & Consulting: workforce strategy, talent pipelines, specialized training and upskilling pathways to develop and transition talent into high-demand infrastructure roles

Across each phase, Kelly Digital Infrastructure is expanding the use of automation and applied AI to help clients improve workforce productivity, project efficiency, and infrastructure performance.

Workforce Solutions in Action

Kelly Digital Infrastructure has already achieved demonstrable results as a combined entity, recently partnering with a leading energy infrastructure firm facing acute labor shortages in emerging data center markets. By transitioning the client from a rigid direct-hire framework to an agile SOW model, Kelly rapidly deployed project managers, mechanical designers, and field engineers, eliminating construction delays and improving worker retention.

To deliver these outcomes at scale, Kelly Digital Infrastructure leverages Kelly’s proven recruiting engine, deeply vetted talent pipelines, and specialized workforce development capabilities. Kelly is also developing purpose-built approaches, such as a data center workforce accelerator program, designed to help clients address talent shortages through assessment, training, upskilling, and deployment of workers from adjacent industries into high-demand infrastructure roles.

To learn more, visit kellyservices.com/divisions/digital-infrastructure.

About Kelly Digital Infrastructure(™)
Kelly Digital Infrastructure™ provides specialized workforce solutions, technical project execution, and talent strategies across the digital infrastructure ecosystem, with expertise in telecommunications, data centers, AI and automation, and power and energy. Built on decades of experience that includes designing more than 250,000 sites and carriers, Kelly Digital Infrastructure delivers contingent staffing, direct hire, technical project services, strategic consulting, and managed programs to help clients build, deploy, operate, and scale critical infrastructure globally.

About Kelly^®
Kelly Services, Inc. (Nasdaq: KELYA, KELYB) helps companies recruit and manage skilled workers and helps job seekers find great work. Since inventing the staffing industry in 1946, we have become experts in the many industries and local and global markets we serve. With a network of suppliers and partners around the world, we connect more than 375,000 people with work every year. Our suite of outsourcing and consulting solutions ensures companies have the people they need, when and where they are needed most. Headquartered in Troy, Michigan, we empower businesses and individuals to access limitless opportunities in industries such as science, engineering, technology, education, manufacturing, retail, finance, and energy. Revenue in 2025 was $4.3 billion. Learn more at kellyservices.com.

Media Contact
Christian Taske
248-561-8823
christian.taske@kellyservices.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/be85fb2b-004a-4e99-8220-515d31aa2a9b

This press release was published by a CLEAR® Verified individual.

NESS ZIONA, Israel, Sept. 30, 2026 (GLOBE NEWSWIRE) — Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company, pioneering treatments for patients with rare and severe skin conditions, today announced it will host a KOL Investor Event on SGT-610 (patidegib gel, 2%) on Wednesday, October 14, 2026 in New York.

The event will feature Julie Breneiser, PA-C (Gorlin Syndrome Alliance), Ervin Epstein Jr., MD (Alta Bates Summit Medical Center), Kavita Sarin, MD, PhD (Stanford Cancer Institute), and Elizabeth M. Billingsley, MD, FAAD, FACMS, FASDS (Penn State College of Medicine), who will discuss the significant disease burden of Gorlin Syndrome patients and lack of effective therapies.

A live webcast of the event will be available through the Sol-Gel Investor Relations website beginning at 12:00 p.m. ET. A replay of the webcast and supporting materials will be available after the conclusion of the event.

Investors and other interested parties may email sol-gel@gilmartinir.com to register for in-person attendance.

About Julie Breneiser, PA-C

Julie Breneiser is the Associate Director of the Gorlin Syndrome Alliance (GSA). Prior to this, she was Executive Director for five years, and President of the Board of Directors. Her early career began as a Physician Assistant. Julie and her two children are affected with Gorlin Syndrome, a rare genetic disorder caused by a tumor suppressant mutation that can affect every organ system. Julie’s work with the GSA focuses on collaboration with industry to bring potential treatments to clinical trial. Under her leadership, the GSA conducted a Listening Session and Patient Focused Drug Development Meeting for the FDA.  Julie previously served as a consumer reviewer for the National Institutes of Health (NIH) and the Department of Defense’s Congressionally Directed Medical Research Programs (DOD-CDMRP). She speaks nationally and internationally, raising awareness of Gorlin Syndrome and the burdens of this multi-system disorder as well as advancing drug development for rare diseases.

About Ervin Epstein, Jr., MD

Dr. Ervin Epstein, Jr., MD was a practicing dermatologist for more than 50 years in the San Francisco Bay Area. He led an academic research lab funded by the National Institutes of Health for 45 years. He served as the Co-Founder, Medical Advisor, and Director at PellePharm, Inc. He also served as Research Dermatologist and Clinical Professor of Dermatology at the University of California, San Francisco, and as President of the Society for Investigative Dermatology. His research interests have focused on the molecular biology of inherited and neoplastic skin diseases. Ervin Epstein has also served on the boards of numerous dermatological organizations including the American Dermatological Association. His publications have appeared in New England Journal of Medicine, Nature, and Science. He received his medical degree from University of California (San Francisco) School of Medicine.

About Kavita Sarin, MD, PhD

Dr. Kavita Sarin, MD, PhD is a Professor of Dermatology and is the Director of the Stanford Skin Cancer Genetics Program at the Stanford Cancer Institute. She received her medical degree from Stanford University School of Medicine and holds a PhD in Genetics from Stanford University. She has an academic interest in Precision Medicine, focused on the integration of genetic and clinical patient data to inform susceptibility, prognosis, and treatments in skin cancer and other rare dermatologic disorders. Her lab applies cutting-edge sequencing and imaging technologies to better understand skin cancer and rare immunologic skin diseases.

About Elizabeth M. Billingsley, MD, FAAD, FACMS, FASDS

Dr. Elizabeth M. Billingsley, MD, FAAD, FACMS, FASDS is a Professor of Dermatology at Penn State University College of Medicine and practices dermatologic surgery and Mohs micrographic surgery with Penn State Health. She received her medical degree from Penn State College of Medicine. She does clinical research and trials in cutaneous oncology and Gorlin Syndrome and is a past President of the American College of Mohs Surgery. Dr. Billingsley is a Fellow of the American Academy of Dermatology (FAAD), the American College of Mohs Surgery (FACMS), and the American Society for Dermatologic Surgery (FASDS), and her clinical practice focuses on the surgical management of skin cancer.

About Sol-Gel Technologies

Sol-Gel is a specialized dermatology company advancing innovative therapies for rare and serios skin diseases. Its lead investigational candidate, SGT-610 (patidegib gel 2%), is a Phase 3, orphan- and breakthrough-designated topical hedgehog inhibitor being developed for the prevention of new basal cell carcinoma (BCC) lesions in patients with Gorlin Syndrome, with the potential to offer an improved safety profile relative to oral hedgehog inhibitors. Subject to regulatory approval in Gorlin Syndrome, SGT-610 may also represent a future opportunity in high-frequency BCC. Sol-Gel is also advancing SGT-210, and investigational topical EGFR inhibitor for indications with significant unmet need, and has developed two FDA-approved dermatology products, TWYNEO^® and EPSOLAY^®.

Forward Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “expect,” “predict,” “potential,” or the negative of these terms or other similar expressions. Forward-looking statements are based on information we have when those statements are made or our management’s current expectations and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause such differences include, but are not limited to, the risk of a delay in reporting the top-line results of Sol-Gel’s pivotal Phase 3 clinical trial of SGT-610 (patidegib gel, 2%) for Gorlin syndrome, that we will not successfully complete the Gorlin Phase 3 clinical trial or that such clinical trial will fail to meet its primary endpoint or one or more of its secondary endpoints as well as the following factors: (i) the adequacy of our financial and other resources, particularly in light of our history of recurring losses; (ii) our ability to complete the development of our product candidates; (iii) our ability to find suitable co-development partners; (iv) our ability to obtain and maintain regulatory approvals for our product candidates in our target markets, the potential delay in receiving such regulatory approvals and the possibility of adverse regulatory or legal actions relating to our product candidates even if regulatory approval is obtained; (v) our collaborators’ ability to commercialize our pharmaceutical product candidates; (vi) our ability to obtain and maintain adequate protection of our intellectual property; (vii) our collaborators’ ability to manufacture our product candidates in commercial quantities, at an adequate quality or at an acceptable cost; (viii) our collaborators’ ability to establish adequate sales, marketing and distribution channels; (ix) acceptance of our product candidates by healthcare professionals and patients; (x) the possibility that we may face third-party claims of intellectual property infringement; (xi) the timing and results of clinical trials that we may conduct or that our competitors and others may conduct relating to our or their products; (xii) intense competition in our industry, with competitors having substantially greater financial, technological, research and development, regulatory and clinical, manufacturing, marketing and sales, distribution and personnel resources than we do; (xiii) potential product liability claims; (xiv) potential adverse federal, state and local government regulation in the United States, China, Europe or Israel; and (xv) loss or retirement of key executives and research scientists; (xvi) general market, political and economic conditions in the countries in which the Company operates; and, (xvii) the security situation in Israel. These factors and other important factors discussed in the Company’s Annual Report on Form 20-F filed with the Securities and Exchange Commission (“SEC”) on March 19, 2026, and our other reports filed with the SEC, could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Except as required by law, we undertake no obligation to update any forward-looking statements in this press release.

Sol-Gel Investor Relations:

Eyal Ben-Or
Chief Financial Officer
ir@sol-gel.com

For Investor Event Inquiries:

Ami Bavishi or Nick Colangelo
Gilmartin Group, LLC
Sol-gel@gilmartinir.com

Integration in Kia’s flagship SUV builds on SoundHound AI’s momentum across fast-growing Asian automotive markets

SANTA CLARA, Calif., Sept. 30, 2026 (GLOBE NEWSWIRE) — SoundHound AI, Inc. (NASDAQ: SOUN), a global leader in voice and agentic AI, today highlighted the deployment of its voice and generative AI technology in the Kia Sorento in India. The integration underscores SoundHound’s deepening footprint across India, reinforcing continuous unit expansion across high-volume international markets.

With the Sorento in India, the Kia AI Assistant with Real-Time Generative AI makes its global debut, marking a first for the Sorento lineup and a category first in the market. Combining SoundHound’s proprietary voice AI platform with advanced generative capabilities, the “Hey Kia” wake-up command delivers continuous, multi-turn conversational support engineered to handle even complex requests in real-time:

• In-Cabin System Control: Drivers can intuitively adjust climate controls, cabin lighting, windows, and driving modes using natural, conversational speech without relying on rigid, pre-programmed phrasing.
• Hands-Free Vehicle Intelligence: Passengers can get instant answers to any question about their vehicle from the digital owner’s manual, and learn about features like hybrid powertrain functions or specialized seating settings.
• Dynamic Conversational Search: The system delivers real-time information, localized point-of-interest navigation, news updates, and contextual Q&A tailored for high-accuracy performance in noisy cabin environments.

“The new Kia Sorento is a standout vehicle, and we’ve delivered an equally powerful voice experience to match. We’re giving drivers effortless control over cabin systems, vehicle knowledge, and live navigation by using natural, everyday speech,” said Keyvan Mohajer, CEO and Co-Founder of SoundHound AI. “As demand for intelligent vehicles accelerates across India, extending our AI technology further into Kia’s premier models marks another leap forward in scaling our technology across high-growth international markets.”

This integration builds on SoundHound’s expanding agentic voice AI deployments across automotive hubs globally, with its OASYS platform driving increased market adoption. By bringing advanced conversational capabilities to Kia’s flagship vehicles, SoundHound continues to scale its intelligent in-cabin technology across key international markets, delivering next-generation connected experiences to millions of drivers.

Learn more at, https://www.soundhound.com/industries/automotive.

About SoundHound AI 
SoundHound AI (Nasdaq:SOUN) is a voice and agentic AI company that enables businesses to deliver natural, end-to-end conversational experiences across digital and physical channels, including phones, kiosks, chat, smart devices, drive-thrus, TVs, in-vehicle, and more. Its agentic platform, OASYS, is a self-learning, orchestrated AI system where organizations can build and deploy conversational AI agents to handle transactions, tasks, and workflows on behalf of customers and employees. Built on proprietary technology backed by 750+ patents and years of AI research, SoundHound serves leading brands across industries including automotive, financial services, healthcare, retail, telecommunications, and more. It powers millions of products and processes billions of interactions annually for enterprise customers worldwide. Learn more at: www.soundhound.com

Media Contact:
Fiona McEvoy
415-610-6590
PR@SoundHound.com  

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/b28aa34d-9ee4-4f6e-be92-112498f0b090

Inside Information

• Agreement provides long-term expanded access to Catalent’s fast-dissolving (Zydis^®) tablet formulation technology.
• Supply robustness secured with prioritised manufacturing capacity increase of ~40% to 1.1 billion tablets annually from early 2030s.
• Over three years, ALK to invest DKK 500 million in capacity at Catalent.

ALK (ALKB:DC / Nasdaq Copenhagen: ALK B) today announced that it has expanded its long-standing contract manufacturing partnership with Catalent, Inc. (“Catalent”), a leader in enabling the development and supply of better treatments for patients worldwide. Establishing long-term supply robustness is a strategic priority for ALK, and the expanded agreement secures ALK long-term access to Catalent’s Zydis^® technology for all its allergen products, including potential future tablets for peanut and tree nut allergies.

The agreement also secures additional production capacity to sustain the expected future demand for ALK’s SLIT (sublingual immunotherapy) tablet portfolio. Based on production sites in the UK and Canada, ALK expects to increase its annual tablet capacity by an additional 300 million to 1.1 billion tablets from early 2030s and beyond.

Peter Halling, President & CEO, said: “We are very pleased to reinforce our long-standing collaboration with Catalent, which plays an important role in producing ALK’s SLIT tablets. This partnership, already in place for more than two decades, has the potential to become one of the longest lasting in pharma. The expanded partnership underscores the unique durability of our core business model – with no patent cliff to manage – while the strengthened supply chain and added capacity secure our ability to serve many more people with allergy for years to come.”

Terms and financials
Under the terms of the agreement, ALK will commit total payments to Catalent of approximately DKK 500 million to secure the capacity expansion. These payments will be capitalised over three years on the balance sheet under ‘prepayments’ and amortised over the duration of the contract. The development in future manufacturing costs is expected to offset these initial payments over time.

The agreement does not affect ALK’s financial guidance for 2026 or ALK’s long-term financial targets.

ALK-Abelló A/S

For further information please contact:

Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525

Media: Maiken Riise Andersen, tel. +45 5054 1434

This announcement contains inside information. This is information that ALK-Abelló A/S is obliged to make public pursuant to the EU Market Abuse Regulation.

About ALK
ALK is a global specialty pharmaceutical company focused on allergy. ALK’s activities cover the entire value chain of developing, sourcing, producing, and marketing a diversified portfolio of products for diagnosing and treating respiratory allergies and severe allergic reactions (anaphylaxis) in both children and adults. Headquartered in Denmark, ALK employs around 2,800 people worldwide and is listed on Nasdaq Copenhagen (Nasdaq: ALK B). Visit us at www.alk.net.

About Catalent
Catalent, Inc. is a leading global contract development and manufacturing organisation (CDMO) delivering tailored, end-to-end solutions across all phases of development and manufacturing for pharma, biotech and consumer health customers, and supplying billions of doses annually from nearly 40 global sites.
Among its proprietary technologies is Zydis^®, a freeze-dried orally disintegrating tablet formulation that disperses almost instantly in the mouth, offering a fast, convenient and palatable dosage form – particularly suited to patients, such as children, who may struggle with conventional tablets.

Attachment

• Company release_15_26UK_300926_Expansion Catalent contract

OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE, 30 SEPTEMBER 2026 at 16.00 P.M. EEST, MANAGERS’ TRANSACTIONS

Oma Savings Bank Plc – Managers’ transactions – Volotinen

____________________________________________

Person subject to the notification requirement

Name: Volotinen, Juha

Position: Member of the Board/Deputy member

Issuer: Oma Savings Bank Plc

LEI: 743700LE1ECAPXC5UT18

Notification type: INITIAL NOTIFICATION

Reference number: 743700LE1ECAPXC5UT18_20260923151926_96

____________________________________________

Transaction date: 2026-09-30

Venue not applicable

Instrument type: SHARE

ISIN: FI4000306733

Nature of the transaction: DISPOSAL

Transaction details

(1): Volume: 3531 Unit price: 17.20 EUR

Aggregated transactions

(1): Volume: 3531 Volume weighted average price: 17.20 EUR

Oma Savings Bank Plc

Additional information:
Karri Alameri, CEO, tel. +358 20 758 3040, karri.alameri@omasp.fi

Distribution:

Nasdaq Helsinki Ltd

Major media

www.omasp.fi

OmaSp is a solvent and profitable Finnish bank. About 600 professionals provide nationwide services through OmaSp’s 48 branch offices and digital service channels to over 200,000 private and SME customers. OmaSp focuses primarily on retail banking operations and provides its clients with a broad range of banking services both through its own balance sheet as well as by acting as an intermediary for its partners’ products. The intermediate products include credit, investment, and loan insurance products. OmaSp is also engaged in mortgage banking operations.

OmaSp’s core idea is to provide personal service to its customers, both in digital and traditional channels. OmaSp strives to offer a premium-level customer experience through personal service and easy accessibility. In addition, the development of operations and services is customer oriented. The personnel are committed, and OmaSp seeks to support their career development with varied tasks and continuous development. A substantial part of the personnel also own shares in OmaSp.

OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE, 30 SEPTEMBER 2026 at 16.00 P.M. EEST, MANAGERS’ TRANSACTIONS

Oma Savings Bank Plc – Managers’ transactions – Virtanen

____________________________________________

Person subject to the notification requirement

Name: Virtanen, Kalle

Position: Other senior manager

Issuer: Oma Savings Bank Plc

LEI: 743700LE1ECAPXC5UT18

Notification type: INITIAL NOTIFICATION

Reference number: 743700LE1ECAPXC5UT18_20260923151926_93

____________________________________________

Transaction date: 2026-09-30

Venue not applicable

Instrument type: SHARE

ISIN: FI4000306733

Nature of the transaction: DISPOSAL

Transaction details

(1): Volume: 353 Unit price: 17.20 EUR

Aggregated transactions

(1): Volume: 353 Volume weighted average price: 17.20 EUR

Oma Savings Bank Plc

Additional information:
Karri Alameri, CEO, tel. +358 20 758 3040, karri.alameri@omasp.fi

Distribution:

Nasdaq Helsinki Ltd

Major media

www.omasp.fi

OmaSp is a solvent and profitable Finnish bank. About 600 professionals provide nationwide services through OmaSp’s 48 branch offices and digital service channels to over 200,000 private and SME customers. OmaSp focuses primarily on retail banking operations and provides its clients with a broad range of banking services both through its own balance sheet as well as by acting as an intermediary for its partners’ products. The intermediate products include credit, investment, and loan insurance products. OmaSp is also engaged in mortgage banking operations.

OmaSp’s core idea is to provide personal service to its customers, both in digital and traditional channels. OmaSp strives to offer a premium-level customer experience through personal service and easy accessibility. In addition, the development of operations and services is customer oriented. The personnel are committed, and OmaSp seeks to support their career development with varied tasks and continuous development. A substantial part of the personnel also own shares in OmaSp.

OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE, 30 SEPTEMBER 2026 at 16.00 P.M. EEST, MANAGERS’ TRANSACTIONS

Oma Savings Bank Plc – Managers’ transactions – Volotinen

____________________________________________

Person subject to the notification requirement

Name: Volotinen, Enni

Position: Closely associated person

Person Discharging Managerial Responsibilities In Issuer

Name: Volotinen Juha

Position: Member of the Board/Deputy member

Issuer: Oma Savings Bank Plc

LEI: 743700LE1ECAPXC5UT18

Notification type: INITIAL NOTIFICATION

Reference number: 743700LE1ECAPXC5UT18_20260923151926_94

____________________________________________

Transaction date: 2026-09-30

Venue not applicable

Instrument type: SHARE

ISIN: FI4000306733

Nature of the transaction: DISPOSAL

Transaction details

(1): Volume: 150 Unit price: 17.20 EUR

Aggregated transactions

(1): Volume: 150 Volume weighted average price: 17.20 EUR

Oma Savings Bank Plc

Additional information:
Karri Alameri, CEO, tel. +358 20 758 3040, karri.alameri@omasp.fi

Distribution:

Nasdaq Helsinki Ltd

Major media

www.omasp.fi

OmaSp is a solvent and profitable Finnish bank. About 600 professionals provide nationwide services through OmaSp’s 48 branch offices and digital service channels to over 200,000 private and SME customers. OmaSp focuses primarily on retail banking operations and provides its clients with a broad range of banking services both through its own balance sheet as well as by acting as an intermediary for its partners’ products. The intermediate products include credit, investment, and loan insurance products. OmaSp is also engaged in mortgage banking operations.

OmaSp’s core idea is to provide personal service to its customers, both in digital and traditional channels. OmaSp strives to offer a premium-level customer experience through personal service and easy accessibility. In addition, the development of operations and services is customer oriented. The personnel are committed, and OmaSp seeks to support their career development with varied tasks and continuous development. A substantial part of the personnel also own shares in OmaSp.

OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE, 30 SEPTEMBER 2026 at 16.00 P.M. EEST, MANAGERS’ TRANSACTIONS

Oma Savings Bank Plc – Managers’ transactions – Sirkiä

____________________________________________

Person subject to the notification requirement

Name: Sirkiä, Hanna

Position: Other senior manager

Issuer: Oma Savings Bank Plc

LEI: 743700LE1ECAPXC5UT18

Notification type: INITIAL NOTIFICATION

Reference number: 743700LE1ECAPXC5UT18_20260923151926_91

____________________________________________

Transaction date: 2026-09-30

Venue not applicable

Instrument type: SHARE

ISIN: FI4000306733

Nature of the transaction: DISPOSAL

Transaction details

(1): Volume: 1663 Unit price: 17.20 EUR

Aggregated transactions

(1): Volume: 1663 Volume weighted average price: 17.20 EUR

Oma Savings Bank Plc

Additional information:
Karri Alameri, CEO, tel. +358 20 758 3040, karri.alameri@omasp.fi

Distribution:

Nasdaq Helsinki Ltd

Major media

www.omasp.fi

OmaSp is a solvent and profitable Finnish bank. About 600 professionals provide nationwide services through OmaSp’s 48 branch offices and digital service channels to over 200,000 private and SME customers. OmaSp focuses primarily on retail banking operations and provides its clients with a broad range of banking services both through its own balance sheet as well as by acting as an intermediary for its partners’ products. The intermediate products include credit, investment, and loan insurance products. OmaSp is also engaged in mortgage banking operations.

OmaSp’s core idea is to provide personal service to its customers, both in digital and traditional channels. OmaSp strives to offer a premium-level customer experience through personal service and easy accessibility. In addition, the development of operations and services is customer oriented. The personnel are committed, and OmaSp seeks to support their career development with varied tasks and continuous development. A substantial part of the personnel also own shares in OmaSp.

OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE, 30 SEPTEMBER 2026 at 16.00 P.M. EEST, MANAGERS’ TRANSACTIONS

Oma Savings Bank Plc – Managers’ transactions – Soikkeli

____________________________________________

Person subject to the notification requirement

Name: Soikkeli, Pirjetta

Position: Other senior manager

Issuer: Oma Savings Bank Plc

LEI: 743700LE1ECAPXC5UT18

Notification type: INITIAL NOTIFICATION

Reference number: 743700LE1ECAPXC5UT18_20260923151926_92

____________________________________________

Transaction date: 2026-09-30

Venue not applicable

Instrument type: SHARE

ISIN: FI4000306733

Nature of the transaction: DISPOSAL

Transaction details

(1): Volume: 242 Unit price: 17.20 EUR

Aggregated transactions

(1): Volume: 242 Volume weighted average price: 17.20 EUR

Oma Savings Bank Plc

Additional information:

Additional information:
Karri Alameri, CEO, tel. +358 20 758 3040, karri.alameri@omasp.fi

Distribution:

Nasdaq Helsinki Ltd

Major media

www.omasp.fi

OmaSp is a solvent and profitable Finnish bank. About 600 professionals provide nationwide services through OmaSp’s 48 branch offices and digital service channels to over 200,000 private and SME customers. OmaSp focuses primarily on retail banking operations and provides its clients with a broad range of banking services both through its own balance sheet as well as by acting as an intermediary for its partners’ products. The intermediate products include credit, investment, and loan insurance products. OmaSp is also engaged in mortgage banking operations.

OmaSp’s core idea is to provide personal service to its customers, both in digital and traditional channels. OmaSp strives to offer a premium-level customer experience through personal service and easy accessibility. In addition, the development of operations and services is customer oriented. The personnel are committed, and OmaSp seeks to support their career development with varied tasks and continuous development. A substantial part of the personnel also own shares in OmaSp.